Nationwide Fund Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,435,693
Closed -$116M 1522
2017
Q3
$116M Sell
3,435,693
-103,900
-3% -$3.34M 0.46% 23
2017
Q2
$113M Sell
3,539,593
-144,714
-4% -$4.56M 0.45% 24
2017
Q1
$120M Buy
3,684,307
+183,313
+5% +$5.78M 0.48% 21
2016
Q4
$108M Sell
3,500,994
-523,403
-13% -$16M 0.45% 23
2016
Q3
$129M Buy
4,024,397
+152,144
+4% +$5.09M 0.54% 16
2016
Q2
$129M Sell
3,872,253
-498,451
-11% -$15.9M 0.56% 18
2016
Q1
$123M Sell
4,370,704
-121,424
-3% -$3.47M 0.53% 20
2015
Q4
$138M Sell
4,492,128
-1,227,160
-21% -$38.6M 0.59% 15
2015
Q3
$170M Buy
5,719,288
+94,028
+2% +$3.01M 0.76% 8
2015
Q2
$179M Buy
5,625,260
+132,175
+2% +$4.31M 0.73% 6
2015
Q1
$181M Buy
5,493,085
+76,756
+1% +$2.44M 0.73% 5
2014
Q4
$160M Sell
5,416,329
-910,354
-14% -$26.1M 0.68% 7
2014
Q3
$177M Sell
6,326,683
-212,946
-3% -$5.98M 0.75% 7
2014
Q2
$184M Sell
6,539,629
-64,124
-1% -$1.83M 0.75% 8
2014
Q1
$201M Buy
6,603,753
+256,463
+4% +$7.65M 0.93% 6
2013
Q4
$184M Sell
6,347,290
-363,570
-5% -$10.6M 0.77% 9
2013
Q3
$183M Buy
6,710,860
+45,357
+0.7% +$1.23M 0.82% 4
2013
Q2
$177M Buy
+6,665,503
New +$184M 0.93% 6

Other funds holding PFE

Nationwide Fund Advisors's PFE Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Pfizer (PFE) in Q4 2017, closing a stake of 3,435,693 shares — an estimated $116M sold.

Nationwide Fund Advisors first reported a position in PFE in Q2 2013 and held it in 18 quarters. The position peaked at $201M in Q1 2014. 2,244 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 3,435,693 Pfizer shares in Q4 2017, an estimated $116M.
  • Nationwide Fund Advisors first reported a position in Pfizer in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Pfizer position peaked at $201M in Q1 2014.
  • 2,244 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.